Hyperfine Inc (HYPR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $66.74M
Last updated: Nov 17, 2026 at 11:05 AM ET
Hyperfine Inc (HYPR) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Hyperfine reported EPS of -$0.07, above the -$0.08 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
HYPR's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
HYPR Earnings Call
The latest HYPR earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 19 quarters below that had an estimate, HYPR beat 8, missed 4 and matched 7. Revenue for the quarter ended Sep 30, 2026 was $5.96M, up 73.3% from $3.44M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.07 | -$0.08 | -$0.09 - -$0.08 | +12.50% | Beat | N/A | 3 | 2 up, 0 down | Nov 9, 2026 | $5.96M |
| Jun 30, 2026 | -$0.09 | -$0.09 | -$0.09 - -$0.09 | 0.00% | In line | N/A | 2 | 0 up, 0 down | Aug 6, 2026 | $3.90M |
| Mar 31, 2026 | -$0.09 | -$0.11 | N/A | +19.73% | Beat | N/A | 2 | 0 up, 0 down | May 12, 2026 | $3.90M |
| Dec 31, 2025 | -$0.08 | -$0.08 | -$0.08 - -$0.08 | 0.00% | In line | N/A | 2 | 1 up, 0 down | Mar 18, 2026 | $5.29M |
| Sep 30, 2025 | -$0.14 | -$0.10 | -$0.11 - -$0.10 | -40.00% | Miss | N/A | 2 | 1 up, 0 down | Nov 13, 2025 | $3.44M |
| Jun 30, 2025 | -$0.12 | -$0.12 | -$0.12 - -$0.12 | 0.00% | In line | N/A | 3 | 0 up, 2 down | Aug 13, 2025 | $2.70M |
| Mar 31, 2025 | -$0.12 | -$0.12 | -$0.12 - -$0.11 | 0.00% | In line | N/A | 4 | 0 up, 0 down | May 13, 2025 | $2.14M |
| Dec 31, 2024 | -$0.14 | -$0.14 | -$0.15 - -$0.12 | 0.00% | In line | N/A | 2 | 0 up, 0 down | Mar 17, 2025 | $2.32M |
| Sep 30, 2024 | -$0.14 | -$0.14 | -$0.14 - -$0.14 | 0.00% | In line | N/A | 3 | 0 up, 0 down | Nov 12, 2024 | $3.64M |
| Jun 30, 2024 | -$0.14 | -$0.14 | -$0.15 - -$0.13 | 0.00% | In line | N/A | 3 | 0 up, 0 down | Aug 8, 2024 | $3.63M |
| Mar 31, 2024 | -$0.14 | -$0.15 | -$0.16 - -$0.14 | +6.67% | Beat | N/A | 3 | 0 up, 0 down | May 13, 2024 | $3.29M |
| Dec 31, 2023 | -$0.15 | -$0.18 | -$0.20 - -$0.16 | +16.67% | Beat | N/A | 3 | 0 up, 0 down | Mar 21, 2024 | $2.69M |
| Sep 30, 2023 | -$0.15 | -$0.16 | -$0.17 - -$0.15 | +6.25% | Beat | N/A | 2 | 0 up, 0 down | Nov 9, 2023 | $2.33M |
| Jun 30, 2023 | -$0.15 | -$0.16 | -$0.17 - -$0.16 | +6.25% | Beat | N/A | 2 | 0 up, 0 down | Aug 14, 2023 | $3.38M |
| Mar 31, 2023 | -$0.17 | -$0.13 | -$0.16 - -$0.11 | -30.77% | Miss | N/A | 3 | 0 up, 0 down | May 11, 2023 | $2.63M |
| Dec 31, 2022 | -$0.19 | -$0.25 | -$0.25 - -$0.20 | +24.00% | Beat | N/A | 3 | 0 up, 0 down | Mar 21, 2023 | $1.42M |
| Sep 30, 2022 | -$0.19 | -$0.26 | -$0.26 - -$0.25 | +26.92% | Beat | N/A | 3 | 0 up, 0 down | Nov 10, 2022 | $2.35M |
| Jun 30, 2022 | -$0.33 | -$0.26 | N/A | -26.92% | Miss | N/A | 1 | 0 up, 0 down | Aug 10, 2022 | $1.53M |
| Mar 31, 2022 | -$0.34 | -$0.21 | -$0.21 - -$0.21 | -61.90% | Miss | N/A | 1 | 0 up, 0 down | May 11, 2022 | $1.51M |
| Dec 31, 2021 | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 23, 2022 | $436000 |
| Sep 30, 2021 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 18, 2021 | $371000 |
| Jun 30, 2021 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 18, 2021 | $358000 |
| Mar 31, 2021 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 17, 2021 | $331000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.46, after -$0.56 the year before. It was -$0.46 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.46 | N/A |
| Dec 31, 2024 | -$0.56 | N/A |
| Dec 31, 2023 | -$0.62 | N/A |
| Dec 31, 2022 | -$1.05 | N/A |
| Dec 31, 2021 | -$0.46 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,400 words across 8 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,364 | 8 | |
| 2026Q2 | Jun 30, 2026 | 3,448 | 6 | |
| 2026Q1 | Mar 31, 2026 | 4,174 | 7 | |
| 2025Q4 | Dec 31, 2025 | 5,011 | 6 | |
| 2025Q3 | Sep 30, 2025 | 4,493 | 7 | |
| 2025Q2 | Jun 30, 2025 | 5,789 | 7 | |
| 2025Q1 | Mar 31, 2025 | 4,808 | 7 | |
| 2024Q4 | Dec 31, 2024 | 5,167 | 7 |
2026Q3 Earnings Call
Opening remarks
Webb Campbell Investor Relations Thank you for joining today's call. Earlier today, Hyperfine, Inc. released financial results for the quarter ended September 30, 2026. A copy of the press release is available on the company's website as well as sec.gov. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities law and made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements, including, without limitation, those relating to our operating trends and future financial performance, expense management, market opportunity, commercial and international expansion, regulatory approvals and product development are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our latest periodic filings with the Securities and Exchange Commission. This conference call contains time-sensitive information and is accurate only as of today's live broadcast. Hyperfine, Inc. disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. With that, I will turn the call over to Maria Sainz, President and Chief Executive Officer.
Maria Sainz President and Chief Executive Officer Good afternoon, and thank you for joining us. On the call with me today is the Chief Administrative Officer and Chief Financial Officer, Brett Hale. The financial results in the third quarter were the strongest in Hyperfine's history. We delivered records across the P&L, revenue, gross profit and gross margin, along with the narrowest operating loss and our lowest quarterly net cash burn. This is not just a great quarter; it marks the beginning of a new trajectory. Revenue was a record $6 million, up 53% sequentially and 73% year-over-year. Gross margin was a record 56.7%. Net cash burn fell 29% sequentially to $5.6 million, and for the first time, quarterly revenue exceeded net cash burn. Brett will walk you through the details. I want to step back and reflect on where we are, who we are, and the significant opportunity in front of us to advance brain health and drive meaningful long-term value for our shareholders.
Frequently Asked Questions About HYPR
Did HYPR beat earnings estimates last quarter?
Yes. Hyperfine reported EPS of -$0.07 for the quarter ended Sep 30, 2026, above the -$0.08 estimate, a 12.50% surprise.
What EPS do analysts expect from HYPR next quarter?
The consensus EPS estimate for Hyperfine for the quarter ending Dec 31, 2026 is -$0.08 from 6 analysts, with estimates from -$0.08 to -$0.07.
How often does HYPR beat earnings estimates?
Hyperfine beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -0.97%.
HYPR pages: Overview, Earnings, Forecast, Financials, Competitors